Skip to content
About
Clinical Trials
Resources
Contact
Menu
About
Clinical Trials
Resources
Contact
Trial Type: Brain Tumors
LS-P-SALT
Phase I trial with KSQ-4279 (ubiquitin specific peptidase 1 [USP1] inhibitor) for tumors with mutations in DNA repair genes.
Status: Open
Trial Type:
Brain Tumors
,
Early Phase Trials for Multiple Cancer Types
Contact: Dr. Benedito Carneiro
Benedito.carneiro@lifespan.org
LS-P-SoNG
Phase 1b study to evaluate eflornithine plus temozolomide in patients with newly diagnosed glioblastoma
Status: Open
Trial Type:
Brain Tumors
Contact: Dr. Eric Wong
ewong1@lifespan.org
LS-P-Survive
SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
Status: Open
Trial Type:
Brain Tumors
Contact: Dr. Eric Wong
ewong1@lifespan.org
LS-P-ImmuneSense
IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF-1R, in Newly Diagnosed Patients With Glioblastoma Multiforme
Status: Open
Trial Type:
Brain Tumors
Contact: Dr. Eric Wong
ewong1@lifespan.org
